newsfilter
← Latest News
Business Wire·

Imago BioSciences Appoints Laurie Keating to Board of Directors

​Imago BioSciences, Inc. (Imago) (NASDAQ:IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced the appointment of Laurie Keating to its Board of Directors